What Should Happen to our Medical Records When We Die?
In the next 200 years, at least 20 billion people will die — and the issue of how best to manage their posthumous medical records is unclear.

Boston area healthcare providers, public safety officials and mental health clinicians will hear from experts on human trafficking including healthcare providers, law enforcement, government officials, outreach workers and survivors at an upcoming conference hosted by the Northeastern University’s School of Nursing.
What does a human rights perspective add to telling us what health inequalities (within and between countries) are inequities and injustices—as opposed to disparities?
Is there a role for the government to play a greater role in making health insurance affordable and accessible? As public support for action on health care grows, what options are available to states now?
In her new book, “Global Health Justice and Governance,” Dr. Prah Ruger lays out the critical problems facing the world today and offers a new theory of justice and governance as a way to resolve these seemingly intractable issues.
Join us March 8 for a talk that will cover the science of genome editing, including CRISPR, and in particular, the scientific advances made in the field since its principal discovery as an engineering tool in 2012.
Join us on Friday for Health Policy Biothics Consortium!
Now is the time to reconsider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
This year brought with it a wave of interesting issues in the health law arena—be it questions of limiting health care access to immigrants, the ongoing challenges of the opioid epidemic, or the ever-changing landscape of drug pricing. Join us as we unpack the major health law developments of 2019 and discuss what to watch…
By Alex Pearlman Anya Prince, a legal scholar and thought leader in the field of genetic discrimination, will present a new paper at Monday’s Health Law Workshop that interrogates whether gene therapies will exacerbate inequalities in health care, as more treatments enter the market. “Gene Therapy’s Field of Dreams: If You Build It, Will We Pay?”…